pipette
ESEspañol

A synthetic heparin oligosaccharide decouples anticoagulation from heparin-induced thrombocytopenia risk

Jian-Qun Deng, Xianxian Duan, Yu-Han Zhao, Yi Li, Ya-Lin Cao, Xin-Yu Li, Chaoyue Li, Wen-Jie Jiang, Feng Xu, Juzheng Sheng

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
This study used chemoenzymatic synthesis to engineer homogeneous dodecasaccharide 12G-2, decoupling anticoagulant efficacy from HIT risk via dual structural modulation.

Appeared: Friday, November 6. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.aeg0408